trial · primary record
T-DXd
Breast Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 139 |
| Primary completion | 2027-06-28 |
| Primary endpoint | Phase I Stage Cohort A: Maximum Tolerated Dose (MTD) |
| Registry ID | NCT07134153 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:51.662Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07134153
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.